TrialLupus science & medicine2024

SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus.

Regina Rendas-Baum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.